Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of remimazolam besylate vs remimazolam tosilate in day hysteroscopy
ChiCTR2400081688Phase 4Not yet recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in procedural pain and anxiety associated with hysteroscopy (2 arms), sponsored by Weifang People's Hospital. Primary endpoint: Dose required for induction of anaesthesia with remimazolam. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
procedural pain and anxiety associated with hysteroscopy
Beyond the preview
Go deeper on ChiCTR2400081688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081688.